Suppr超能文献

联合光致敏和接种疫苗可独立于 CD4 T 细胞辅助作用诱导 CD8 T 细胞免疫和肿瘤抑制。

Combined Photosensitization and Vaccination Enable CD8 T-Cell Immunity and Tumor Suppression Independent of CD4 T-Cell Help.

机构信息

Department of Dermatology, University of Zurich, Zurich, Switzerland.

Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.

出版信息

Front Immunol. 2019 Jul 5;10:1548. doi: 10.3389/fimmu.2019.01548. eCollection 2019.

Abstract

Cytotoxic T lymphocytes (CTLs) are key players in fighting cancer, and their induction is a major focus in the design of therapeutic vaccines. Yet, therapeutic vaccine efficacy is limited, in part due to the suboptimal vaccine processing by antigen-presenting cells (APCs). Such processing typically takes place via the MHC class II pathway for CD4 T-cell activation and MHC class I pathway for activation of CD8 CTLs. We show that a combination of skin photochemical treatment and immunization, so-called photochemical internalization (PCI) facilitated CTL activation due to the photochemical adjuvant effect induced by photosensitizer, oxygen, and light. Mice were immunized intradermally with antigen and photosensitizer, followed by controlled light exposure. PCI-treated mice showed strong activation of CD8 T cells, with improved IFN-γ production and cytotoxicity, as compared to mice immunized without parallel PCI treatment. Surprisingly, the CD8 T-cell effector functions were not impaired in MHC class II- or CD4 T-cell-deficient mice. Moreover, PCI-based vaccination caused tumor regression independent of MHC class II or CD4 T cells presence in melanoma bearing mice. Together, the data demonstrate that PCI can act as a powerful adjuvant in cancer vaccines, even in hosts with impaired T-helper functions.

摘要

细胞毒性 T 淋巴细胞(CTLs)是抗癌的关键因素,其诱导是治疗性疫苗设计的主要焦点。然而,治疗性疫苗的疗效有限,部分原因是抗原呈递细胞(APCs)对疫苗的处理不理想。这种处理通常通过 MHC 类 II 途径进行 CD4 T 细胞的激活,通过 MHC 类 I 途径进行 CD8 CTL 的激活。我们表明,皮肤光化学处理和免疫接种的组合,即所谓的光化学内化(PCI),由于光增敏剂、氧气和光诱导的光化学佐剂效应,促进了 CTL 的激活。用抗原和光增敏剂对小鼠进行皮内免疫,然后进行受控的光暴露。与未经平行 PCI 处理的免疫小鼠相比,PCI 处理的小鼠表现出强烈的 CD8 T 细胞激活,IFN-γ产生和细胞毒性得到改善。令人惊讶的是,在 MHC 类 II 或 CD4 T 细胞缺陷型小鼠中,CD8 T 细胞的效应功能并未受损。此外,基于 PCI 的疫苗接种可导致肿瘤消退,而与黑色素瘤荷瘤小鼠中 MHC 类 II 或 CD4 T 细胞的存在无关。总之,这些数据表明,即使在 T 辅助功能受损的宿主中,PCI 也可以作为癌症疫苗的强大佐剂。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验